IL275624B

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory metabolic, oncologic and autoimmune diseases

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

95 members in 33 offices

This recordMember, by publication datePriority claim23 more offices are in the list below

Priority claims14

Priority claims
DocumentOfficeKindDate
1450920SwedenA
1450920SwedenA
14509202Sweden
1451406SwedenA
1451406SwedenA
14514061Sweden
2015067692European Patent Office (EPO)W
2015067692European Patent Office (EPO)W
14509202
14514061
PCTEP2015067692
SE20140050920
SE20140051406
WO2015EP67692

Members95

Family members, oldest first
DocumentOfficeKind
CA2957046A1CanadaA1
CA2957048A1CanadaA1
WO2016020288A1World Intellectual Property Organization (WIPO)A1
WO2016020295A1World Intellectual Property Organization (WIPO)A1
SG11201700777VASingaporeA
SG11201700779RASingaporeA
AU2015299142A1AustraliaA1
AU2015299149A1AustraliaA1
KR20170031784ARepublic of KoreaA
KR20170032470ARepublic of KoreaA
IL250324A0IsraelA0
IL250324D0IsraelD0
IL250325A0IsraelA0
IL250325D0IsraelD0
CN106573899AChinaA
CN106661002AChinaA
CO2017002159A2ColombiaA2
CO2017002160A2ColombiaA2
EP3177611A1European Patent Office (EPO)A1
EP3177612A1European Patent Office (EPO)A1
MA40553AMoroccoA
MA40553AMoroccoA
PE20170682A1PeruA1
PE20170684A1PeruA1
CR20170076ACosta RicaA
CR20170077ACosta RicaA
PH12017500163A1PhilippinesA1
PH12017500164A1PhilippinesA1
MX2017001553AMexicoA
MX2017001554AMexicoA
JP2017523192AJapanA
JP2017523193AJapanA
CL2017000270A1ChileA1
CL2017000271A1ChileA1
US2017327503A1United States of AmericaA1
US2017342074A1United States of AmericaA1
BR112017002214A2BrazilA2
BR112017002217A2BrazilA2
RU2017104614ARussian FederationA
RU2017104612ARussian FederationA
RU2017104614A3Russian FederationA3
RU2017104612A3Russian FederationA3
GT201700023AGuatemalaA
JP6604664B2JapanB2
JP6624594B2JapanB2
JP2020023534AJapanA
AU2015299149B2AustraliaB2
RU2719422C2Russian FederationC2
AU2015299142B2AustraliaB2
US10683293B2United States of AmericaB2
US10689383B2United States of AmericaB2
SG10202006053UASingaporeA
IL250324AIsraelA
IL250324BIsraelB
AU2020213282A1AustraliaA1
IL250325AIsraelA
IL250325BIsraelB
IL275624D0IsraelD0
RU2734261C2Russian FederationC2
US2020392140A1United States of AmericaA1
IL275624AIsraelA
IL275624BThis recordIsraelB
NZ729138ANew ZealandA
CN106573899BChinaB
MA40552AMoroccoA
CN106661002BChinaB
EP3177611B1European Patent Office (EPO)B1
AU2020213282B2AustraliaB2
US11254681B2United States of AmericaB2
EP3177612B1European Patent Office (EPO)B1
FI3177612T3FinlandT3
DK3177612T3DenmarkT3
ES2911707T3SpainT3
HRP20220522T1CroatiaT1
LT3177612TLithuaniaT
JP7091596B2JapanB2
MA40553B1MoroccoB1
RS63190B1SerbiaB1
SMT202200197T1San MarinoT1
NZ729137ANew ZealandA
PL3177612T3PolandT3
SI3177612T1SloveniaT1
CA2957046CCanadaC
MY194204AMalaysiaA
ZA201700672BSouth AfricaB
MY195016AMalaysiaA
BR112017002214B1BrazilB1
KR102523430B1Republic of KoreaB1
CA2957048CCanadaC
KR102538658B1Republic of KoreaB1
NZ766530ANew ZealandA
ZA201700671BSouth AfricaB
CY1125326T1CyprusT1
MX382747BMexicoB
MX381819BMexicoB